siegel. big break in the case. what should we take from it? first problem is kathleen sebelius is not a physician and she has been saying that from the beginning. i m not qualified to say who should get a transplant and who shun. she and who shouldn t. she has the ability to approve this or create a pilot trial where children like sarah can be in this. i think it is amazing and wonderful the judge has come out like this. the technology is changing. the technology is different than it was a few years ago when this policy came into place. children can now get part of adult lungs. not entire lungs. we have the ability to do those kind of transplants. that makes it more important that children ben they re younger. statistics show they actually will do better than adolescents who have raeupbling hormones who have raging hormones to deal with. cystic fibrosis also is
them to a computer which feeds the signals to the robot happening, all in the blink of an eye and the technology is in the early stages, but the benefits could be life changing, obviously. for example, watch this. you can see the robot arm lift the bottle of coffee so the woman can take a sip. see that? she is doing that with her brain. the scientists say her brain did all of the work. the journal nature, released this video and this is a scientist behind the project, dr. lee, an engineering professor at brown university and a critical care neurologist. how in the world did you get this done, doctor, congratulations? guest: thank you very much. just as you described, there were two participants that we are reporting both have, are unable to move their hands and no functional use of their armors legs and they both are unable to speak. they both enrolled in our pilot
basically is the active ingredient in mushrooms, or magic mushrooms. walk us through kind of what you re finding. we re doing a small pilot trial at nyu looking at patients that have advance order cancer are anxious or depressed in pain. we re looking to recruit 30 people. so far it s three. it s a double blind study, it s placebo-controlled. of the three people we have treated so far, we have seen in all three of them a reduction in anxiety around death, diminished depression, and in some diminished pain, greater integration back into their families, back into their lives, living their lives more authentically, resolving unresolved conflicts. three is a pretty small number. that s why this is subjective clinical assessment of our clinicians. we don t know anything until we have analyzed the data. i do want to point out that i think is important here when we re talking about this. all these studies, dr. ross s studies, other ones are done in a controlled setting. they re done